Detalhe da pesquisa
1.
Risk-Based Selection for Active Surveillance: Results of the Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance (GAP3) Initiative.
J Urol
; 206(1): 62-68, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33617330
2.
Comparing the prediction of prostate biopsy outcome using the Chinese Prostate Cancer Consortium (CPCC) Risk Calculator and the Asian adapted Rotterdam European Randomized Study of Screening for Prostate Cancer (ERSPC) Risk Calculator in Chinese and European men.
World J Urol
; 39(1): 73-80, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-32279141
3.
E-bike and classic bicycle-related traumatic brain injuries presenting to the emergency department.
Emerg Med J
; 38(4): 279-284, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33472871
4.
Prostate cancer upgrading with serial prostate magnetic resonance imaging and repeat biopsy in men on active surveillance: are confirmatory biopsies still necessary?
BJU Int
; 126(1): 124-132, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32232921
5.
External validation of novel magnetic resonance imaging-based models for prostate cancer prediction.
BJU Int
; 125(3): 407-416, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31758738
6.
Predicting biochemical recurrence and prostate cancer-specific mortality after radical prostatectomy: comparison of six prediction models in a cohort of patients with screening- and clinically detected prostate cancer.
BJU Int
; 124(4): 635-642, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31055875
7.
Age, gender, functional KSS, reason for revision and type of bone defect predict functional outcome 5 years after revision total knee arthroplasty: a multivariable prediction model.
Knee Surg Sports Traumatol Arthrosc
; 27(7): 2289-2296, 2019 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-30689000
8.
Reducing Biopsies and Magnetic Resonance Imaging Scans During the Diagnostic Pathway of Prostate Cancer: Applying the Rotterdam Prostate Cancer Risk Calculator to the PRECISION Trial Data.
Eur Urol Open Sci
; 36: 1-8, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-35098168
9.
Development of a prediction model in female pure or predominant urge urinary incontinence: a retrospective cohort study.
Ther Adv Urol
; 14: 17562872221090319, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35464652
10.
Assessing a patient's individual risk of biopsy-detectable prostate cancer: Be aware of case mix heterogeneity and a priori likelihood.
Eur Urol Oncol
; 4(5): 813-816, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31431394
11.
Adherence to Active Surveillance Protocols for Low-risk Prostate Cancer: Results of the Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance Initiative.
Eur Urol Oncol
; 3(1): 80-91, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31564531
12.
A Tool for Shared Decision Making on Referral for Prostate Biopsy in the Primary Care Setting: Integrating Risks of Cancer with Life Expectancy.
J Pers Med
; 9(2)2019 Apr 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-31013571
13.
Reducing unnecessary biopsies while detecting clinically significant prostate cancer including cribriform growth with the ERSPC Rotterdam risk calculator and 4Kscore.
Urol Oncol
; 37(2): 138-144, 2019 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-30528698
14.
Prediction of High-grade Prostate Cancer Following Multiparametric Magnetic Resonance Imaging: Improving the Rotterdam European Randomized Study of Screening for Prostate Cancer Risk Calculators.
Eur Urol
; 75(2): 310-318, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30082150
15.
What is an acceptable false negative rate in the detection of prostate cancer?
Transl Androl Urol
; 7(1): 54-60, 2018 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-29594020
16.
Head-to-head comparison of prostate cancer risk calculators predicting biopsy outcome.
Transl Androl Urol
; 7(1): 18-26, 2018 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-29594016
17.
Reporting and Interpreting Decision Curve Analysis: A Guide for Investigators.
Eur Urol
; 74(6): 796-804, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30241973
18.
Reduction of MRI-targeted biopsies in men with low-risk prostate cancer on active surveillance by stratifying to PI-RADS and PSA-density, with different thresholds for significant disease.
Transl Androl Urol
; 7(1): 132-144, 2018 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-29594027
19.
Improving the Rotterdam European Randomized Study of Screening for Prostate Cancer Risk Calculator for Initial Prostate Biopsy by Incorporating the 2014 International Society of Urological Pathology Gleason Grading and Cribriform growth.
Eur Urol
; 72(1): 45-51, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28162815
20.
Reply by authors: Reducing unnecessary biopsies while detecting clinically significant prostate cancer including cribriform growth with the ERSPC Rotterdam risk calculator and 4Kscore.
Urol Oncol
; 37(6): 341-342, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30857989